Key facts
- Notable investors include Paramita Venture.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for dLife
- ·The full record, as it builds
Funding rounds
No funding rounds for dLife are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About dLife
Developer of a decentralized bio-infrastructure platform designed to empower individuals with ownership and control over their genomic and multi-omics data. The company offers privacy-preserving digital identity through DNA, encrypted data tokenization, and programmable omics assets, enabling Web3 users, researchers, and health-focused communities to access secure, user-consented biological data for ethical innovation and personalized applications.
- Sector
- Information Technology
- HQ
- China
- Website
- dlife.xyz/
- Ownership
- Privately Held (backing)
dLife doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in dLife shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on dLife in its N-PORT filings yet. We sweep new filings monthly.